ViewRay designs, manufactures and markets the ViewRay MRIdian®. The MRIdian is a system that integrates radiation therapy with simultaneous magnetic resonance imaging (MRI). There are two generations of the MRIdian: the first generation MRIdian with Cobalt-60 based radiation beams and the second generation MRIdian Linac, with linear accelerator or linac based radiation beams. MRIdian integrates MRI technology, radiation delivery and Co.'s proprietary software to see the soft tissues, shape the dose to accommodate for changes in anatomy and strike the target using real-time targeting throughout the treatment. The MRIdian system is sized to fit into radiation therapy vaults. The VRAY stock yearly return is shown above.
The yearly return on the VRAY stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2021 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the VRAY annual return calculation with any dividends reinvested as applicable (on ex-dates).
|